Results: Among 65 CRPS after-stroke patients, 53 patients (81.54%) presented with neurogenic inflammation, 10 patients (15.38%) with nociceptive sensitization, 10 patients (15.38%) with vasomotor dysfunction and 10 patients (15.38%) with muscle atrophy.